BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36317165)

  • 21. The Results of Peritoneal Re-Approximation Methods on Symptomatic Lymphocele Formation in Robot-Assisted Laparoscopic Radical Prostatectomy and Extended Pelvic Lymphadenectomy.
    Yılmaz K; Ölçücü MT; Arı Ö; Karamik K; Aktaş Y; Savaş M; Ateş M
    Arch Esp Urol; 2022 Jun; 75(5):447-452. PubMed ID: 35983817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature.
    Ploussard G; Briganti A; de la Taille A; Haese A; Heidenreich A; Menon M; Sulser T; Tewari AK; Eastham JA
    Eur Urol; 2014 Jan; 65(1):7-16. PubMed ID: 23582879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic Value of Standard Versus Extended Pelvic Lymph Node Dissection During Radical Prostatectomy for High-Risk Prostate Cancer.
    Colicchia M; Sharma V; Abdollah F; Briganti A; Jeffrey Karnes R
    Curr Urol Rep; 2017 Jul; 18(7):51. PubMed ID: 28589397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the diagnostic efficacy and perioperative outcomes of limited versus extended pelvic lymphadenectomy during robot-assisted radical prostatectomy: a multi-institutional retrospective study in Japan.
    Morizane S; Honda M; Fukasawa S; Komaru A; Inokuchi J; Eto M; Shimbo M; Hattori K; Kawano Y; Takenaka A
    Int J Clin Oncol; 2018 Jun; 23(3):568-575. PubMed ID: 29230586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended versus standard pelvic lymphadenectomy during robot-assisted radical prostatectomy: the role of extended template as an independent predictor of lymph node invasion with comparable morbidity burden.
    Mistretta FA; Boeri L; Grasso AA; Lo Russo V; Albo G; DE Lorenzis E; Maggioni M; Palmisano F; Dell'orto P; Bosari S; Rocco B
    Minerva Urol Nefrol; 2017 Oct; 69(5):475-485. PubMed ID: 28281741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen (
    Huits TH; Luiting HB; van der Poel HG; Nandurkar R; Donswijk M; Schaake E; Vogel W; Roobol MJ; Wit E; Stricker P; Emmett L; van Leeuwen PJ
    BJU Int; 2020 Jun; 125(6):876-883. PubMed ID: 32181951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective Randomized Trial Comparing Titanium Clips to Bipolar Coagulation in Sealing Lymphatic Vessels During Pelvic Lymph Node Dissection at the Time of Robot-assisted Radical Prostatectomy.
    Grande P; Di Pierro GB; Mordasini L; Ferrari M; Würnschimmel C; Danuser H; Mattei A
    Eur Urol; 2017 Feb; 71(2):155-158. PubMed ID: 27544575
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Ferraro DA; Muehlematter UJ; Garcia Schüler HI; Rupp NJ; Huellner M; Messerli M; Rüschoff JH; Ter Voert EEGW; Hermanns T; Burger IA
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):147-159. PubMed ID: 31522272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefit of a more extended pelvic lymph node dissection among patients undergoing radical prostatectomy for localized prostate cancer: A causal mediation analysis.
    Wettstein MS; David LA; Pazhepurackel C; Qureshi AA; Zisman A; Nesbitt M; Saba K; Herrera-Caceres JO; Fankhauser CD; Ahmad A; Hamilton RJ; Eberli D; Zlotta AR; Sulser T; Fleshner NE; Poyet C; Finelli A; Hermanns T; Kulkarni GS
    Prostate; 2021 Apr; 81(5):286-294. PubMed ID: 33599318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation and head-to-head comparison of three nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended and/or sentinel lymph node dissection.
    Grivas N; Wit E; Tillier C; van Muilekom E; Pos F; Winter A; van der Poel H
    Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2213-2226. PubMed ID: 28780722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Autologous Fibrin Glue on Lymphatic Drainage and Lymphocele Formation in Extended Bilateral Pelvic Lymphadenectomy in Robot-Assisted Radical Prostatectomy.
    Garayev A; Aytaç Ö; Tavukcu HH; Atug F
    J Endourol; 2019 Sep; 33(9):761-766. PubMed ID: 31187653
    [No Abstract]   [Full Text] [Related]  

  • 32. Thromboembolic complications in 3,544 patients undergoing radical prostatectomy with or without lymph node dissection.
    Tyritzis SI; Wallerstedt A; Steineck G; Nyberg T; Hugosson J; Bjartell A; Wilderäng U; Thorsteinsdottir T; Carlsson S; Stranne J; Haglind E; Wiklund NP;
    J Urol; 2015 Jan; 193(1):117-25. PubMed ID: 25158271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of extended pelvic lymph node dissection on the risk of hospital readmission within 180 days after robot assisted radical prostatectomy.
    Sebben M; Tafuri A; Shakir A; Pirozzi M; Processali T; Rizzetto R; Amigoni N; Tiso L; De Michele M; Panunzio A; Cerrato C; Brunelli M; Migliorini F; Novella G; De Marco V; Siracusano S; Artibani W; Porcaro AB
    World J Urol; 2020 Nov; 38(11):2799-2809. PubMed ID: 31980875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended pelvic lymph node dissection at the time of robot-assisted radical prostatectomy: Impact of surgical volume on efficacy and complications in a single-surgeon series.
    Di Pierro GB; Grande P; Wirth JG; Danuser H; Mattei A
    Can Urol Assoc J; 2015; 9(3-4):107-13. PubMed ID: 26085867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complications of pelvic lymphadenectomy in 1,380 patients undergoing radical retropubic prostatectomy between 1993 and 2006.
    Musch M; Klevecka V; Roggenbuck U; Kroepfl D
    J Urol; 2008 Mar; 179(3):923-8; discussion 928-9. PubMed ID: 18207170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Undetectable PSA after radical prostatectomy is more likely in low burden N+ prostate cancer patients when an extended lymph node dissection is performed.
    Ramírez-Backhaus M; Mir Maresma MC; Mascarós JM; Bertolo R; Hernández J; Gómez Ferrer A; Casanova-Ramón Borja J; Domínguez Escrig JL; Collado-Serra A; Calatrava Fons A; Rubio-Briones J
    Actas Urol Esp (Engl Ed); 2019 Nov; 43(9):480-487. PubMed ID: 31174878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended pelvic lymph node dissection including internal iliac packet should be performed during robot-assisted laparoscopic radical prostatectomy for high-risk prostate cancer.
    Jung JH; Seo JW; Lim MS; Lee JW; Chung BH; Hong SJ; Song JM; Rha KH
    J Laparoendosc Adv Surg Tech A; 2012 Oct; 22(8):785-90. PubMed ID: 22967037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
    Briganti A; Capitanio U; Chun FK; Gallina A; Suardi N; Salonia A; Da Pozzo LF; Colombo R; Di Girolamo V; Bertini R; Guazzoni G; Karakiewicz PI; Montorsi F; Rigatti P
    Eur Urol; 2008 Oct; 54(4):794-802. PubMed ID: 18514383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended pelvic lymph node dissection in robotic-assisted radical prostatectomy: surgical technique and initial experience.
    Yee DS; Katz DJ; Godoy G; Nogueira L; Chong KT; Kaag M; Coleman JA
    Urology; 2010 May; 75(5):1199-204. PubMed ID: 20163838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended versus limited pelvic lymph node dissection during bilateral nerve-sparing radical prostatectomy and its effect on continence and erectile function recovery: long-term results and trifecta rates of a comparative analysis.
    Hatzichristodoulou G; Wagenpfeil S; Wagenpfeil G; Maurer T; Horn T; Herkommer K; Hegemann M; Gschwend JE; Kübler H
    World J Urol; 2016 Jun; 34(6):811-20. PubMed ID: 26420596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.